52478 Federal Register / Vol. 86, No. 180 / Tuesday, September 21, 2021 / Notices 

Monographs@FDA portal at https://

www.accessdata.fda.gov/scripts/cder/ 

omuf/index.cfm, to the extent the 

corresponding deemed final order has 

been added to the portal. Additionally, 

in either the same notice or a separate 

notice in the Federal Register, pursuant 

to section 505G(k)(3) of the FD&C Act, 

FDA intends to withdraw certain 

portions of the regulations governing the 

OTC drug review, and to make certain 

technical changes. 

IV. Paperwork Reduction Act of 1995 

Under section 505G(o) of the FD&C 

Act, the Paperwork Reduction Act of 

1995 (Chapter 35 of title 44, United 

States Code) does not apply to 

collections of information made under 

section 505G of the FD&C Act. 

Therefore, clearance by the Office of 

Management and Budget under the 

Paperwork Reduction Act of 1995 is not 

required for collections of information, 

if any, in orders deemed to be final 

orders by section 505G of the FD&C Act. 

Dated: September 16, 2021. 

Lauren K. Roth, 

Acting Principal Associate Commissioner for 

Policy. 

[FR Doc. 2021–20393 Filed 9–20–21; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–0990–0281] 

Agency Father Generic Information 

Collection Request; 30-Day Public 

Comment Request 

AGENCY: Office of the Secretary, Health 

and Human Service, HHS. 

ACTION: Notice and request for 

comments. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before October 21, 2021. 

ADDRESSES: Submit your comments to 

OIRA_submission@omb.eop.gov or via 

facsimile to (202) 395–5806. 

FOR FURTHER INFORMATION CONTACT: 

Sherrette Funn, Sherrette.Funn@hhs.gov 

or (202) 795–7714. When requesting 

information, please include the 

document identifier 0990–0281–30D 

and project title for reference. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: Prevention 

Communication Formative Research. 

Type of Collection: Extension. 

OMB No.: 0990–0281—Office of 

Disease Prevention and Health 

Promotion. 

Abstract: The Office of Disease 

Prevention and Health Promotion 

(ODPHP) is focused on developing and 

disseminating health information to the 

public. ODPHP faces an increasingly 

urgent interest in finding effective ways 

to communicate health information to 

America’s diverse population. ODPHP 

strives to be responsive to the needs of 

America’s diverse audiences while 

simultaneously serving all Americans 

across a range of channels, from print to 

new communication technologies. To 

carry out prevention information efforts, 

ODPHP is committed to conducting 

formative and usability research to 

provide guidance on the development 

and implementation of their 

communication and education efforts. 

The information collected will be used 

to improve communication, products, 

and services that support key office 

activities including: Healthy People, 

Dietary Guidelines for Americans, 

Physical Activity Guidelines for 

Americans, MyHealthfinder, the Move 

Your Way® Campaign, the President’s 

Council on Sports, Fitness & Nutrition, 

health literacy and healthy aging. 

ODPHP communicates through its 

websites (www.health.gov) and through 

other channels including social media, 

print materials, interactive training 

modules, and reports. This request 

builds on previous formative research 

approaches to place more emphasis on 

Web-based data collection to allow 

greater geographical diversity among 

respondents, to decrease respondent 

burden, and to save government costs. 

Data collection will be qualitative and 

quantitative and may include in-depth 

interviews, focus groups, web-based 

surveys, omnibus surveys, card sorting, 

and various forms of usability testing of 

materials and interactive tools to assess 

the public’s understanding of disease 

prevention and health promotion 

content, responses to prototype 

materials, and barriers to effective use. 

The program is requesting a 3-year 

clearance. The type of respondents are 

consumers and health professionals 

which will be surveyed on an annual 

basis. 

ESTIMATED ANNUALIZED BURDEN TABLE

Type of respondent Number of 

respondents 

Number 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden hours 

Consumers (screening & omnibus survey) ..................................................... 7725 1 10/60 1287.5 

Consumers (qualitative testing) ....................................................................... 1250 1 1 1250 

Consumers (focus groups) .............................................................................. 575 1 1.5 862.5 

Consumers (screening & intercepts) ............................................................... 35250 1 5/60 2937.5 

Consumers (survey) ........................................................................................ 10000 1 15/60 2500 

Consumers (gatekeeper reviews) .................................................................... 325 1 30/60 162.5 

Consumers (cognitive tests) ............................................................................ 50 1 2 100 

Health care professionals (screening) ............................................................. 1350 1 10/60 225 

Health care professionals (interview) .............................................................. 50 1 1 50 

Health care professionals (focus group) .......................................................... 400 1 1.5 600 

Total .......................................................................................................... ........................ ........................ ........................ 9,975 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 180 / Tuesday, September 21, 2021 / Notices 52479 

Sherrette A. Funn, 

Paperwork Reduction Act Reports Clearance 

Officer, Office of the Secretary. 

[FR Doc. 2021–20324 Filed 9–20–21; 8:45 am] 

BILLING CODE 4150–32–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Tropical Medicine Research 

Centers (U01 Clinical Trial Not Allowed). 

Date: October 18–19, 2021. 

Time: 10:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G62A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Eleazar Cohen, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G62A, Rockville, MD 

20852, (240) 669–5081, ecohen@

niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: September 15, 2021. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–20370 Filed 9–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the NIH Clinical Center 

Research Hospital Board. 

The meeting will be held as a virtual 

meeting and open to the public. 

Individuals who plan to view the virtual 

meeting and need special assistance or 

other reasonable accommodations to 

view the meeting should notify the 

Contact Person listed below in advance 

of the meeting. The meeting can be 

accessed from the NIH video https://

videocast.nih.gov/ and the CCRHB 

website https://ccrhb.od.nih.gov/ 

meetings.html. 

Name of Committee: NIH Clinical Center 

Research Hospital Board. 

Date: October 15, 2021. 

Time: 9:00 a.m. to 1:00 p.m. 

Agenda: CC CEO Update, Patient Safety 

and Clinical Quality Update, other business 

of the Board. 

Place: National Institutes of Health, 

Building 1, 9000 Rockville Pike, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Gretchen Wood, Staff 

Assistant, National Institutes of Health, 

Office of the Director, One Center Drive, 

Building 1, Room 126, Bethesda, MD 20892, 

301–496–4272, woodgs@od.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.14, Intramural Research 

Training Award; 93.22, Clinical Research 

Loan Repayment Program for Individuals 

from Disadvantaged Backgrounds; 93.232, 

Loan Repayment Program for Research 

Generally; 93.39, Academic Research 

Enhancement Award; 93.936, NIH Acquired 

Immunodeficiency Syndrome Research Loan 

Repayment Program; 93.187, Undergraduate 

Scholarship Program for Individuals from 

Disadvantaged Backgrounds, National 

Institutes of Health, HHS) 

Dated: September 15, 2021. 

Patricia B. Hansberger, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2021–20369 Filed 9–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health 

(NIMH); Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Interagency Autism 

Coordinating Committee. 

The purpose of the IACC meeting is 

to discuss business, agency updates, and 

issues related to autism spectrum 

disorder (ASD) research and services 

activities. The meeting will be held as 

a virtual meeting and is open to the 

public. Individuals who plan to view 

the virtual meeting and need special 

assistance or other reasonable 

accommodations to view the meeting 

should notify the Contact Person listed 

below at least seven (7) business days in 

advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocast 

website (http://videocast.nih.gov/). 

Name of Committee: Interagency Autism 

Coordinating Committee (IACC). 

Date: October 13–14, 2021 Meeting 

schedule subject to change. 

Time: 1:00 p.m. to 5:00 p.m. 

Meeting Access: Wednesday, October 13, 

2021 https://videocast.nih.gov/watch=42377 

Thursday, October 14, 2021 https://videocast.

nih.gov/watch=42378. 

Agenda: To discuss business, updates, and 

issues related to ASD research and services 

activities. 

Cost: The meeting is free and open to the 

public. 

Registration: A registration web link will 

be posted on the IACC website 

(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended. 

Deadlines: Written/Virtual Public 

Comment Due Date: Friday, October 1, 2021, 

by 5:00 p.m. ET, For instructions, see below. 

Contact Person: Ms. Rebecca Martin, Office 

of Autism Research Coordination, National 

Institute of Mental Health, NIH, 6001 

Executive Boulevard, Bethesda, MD 20892– 

9669, Phone: 301–435–0886, Email: 

IACCPublicInquiries@mail.nih.gov. 

Public Comments 

The IACC welcomes public comments 

from members of the autism 

community. As the IACC will be 

updating its Strategic Plan, comments 

related to issues that the community 

would like to see highlighted in the new 

IACC Strategic Plan are welcome. 

Comments may be submitted in writing 

via email to IACCPublicInquiries@

mail.nih.gov or using the web form at: 

https://iacc.hhs.gov/meetings/publiccomments/submit/index.jsp by 5:00 

p.m. ET on Friday, October 1, 2021. A 

limited number of slots are available for 


lotter on DSK11XQN23PROD with NOTICES1